budoprutug

Drug identity checked against registry records

Also recorded as TNT119

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
A Phase 2 Study of Budoprutug in Subjects With Primary Membranous NephropathyNCT07096843CLYMPhase 2Recruiting2027-10Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.